Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

XERS Gross Margin

The Gross Margin of Xeris Biopharma Holdings Inc (XERS) is 81.86%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

XERS Gross Margin - Historical Value
Date Value
2024-12-31 81.86%
2023-12-31 82.52%
2022-12-31 79.49%
2021-12-31 73.19%
2020-12-31 54.41%
2019-12-31 40.74%
2018-12-31 96.00%
2017-12-31 100.00%
2016-12-31 100.00%
XERS Gross Margin - Peers Comparison